ClearPoint Neuro, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Statements of Stockholders' Deficit

Statements of Stockholders' Deficit (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Total
Balances, Convertible Preferred Stock Series A, Amount at Dec. 31, 2012	$ 484,187	$ 58,995,972	$ (1,679,234)	$ (65,666,328)	$ (7,865,403)us-gaap_StockholdersEquity
Balances, Convertible Preferred Stock Series A, Shares (in Shares) at Dec. 31, 2012	48,093,000
Private Placement, Common Stock, Amount	92,017	6,407,533			6,499,550
Private Placement, Common Stock, Shares (in Shares)	9,201,684
Share-based compensation		1,458,271			1,458,271
Warrant exercises	11,278	8,347			19,625
Warrant exercises (in Shares)	1,127,829
Issuance of common stock in payment, amount	1,145	139,117			140,262
Issuance of common stock in payment, shares (in Shares)	114,459
Retirement of treasury stock	(3,258)	(1,675,976)	1,679,234
Net loss for the year				(7,086,274)	(7,086,274)us-gaap_NetIncomeLoss
Balances, Convertible Preferred Stock Series A, Amount at Dec. 31, 2013	585,369	65,333,264		(72,752,602)	(6,833,969)us-gaap_StockholdersEquity
Balances, Convertible Preferred Stock Series A, Shares (in Shares) at Dec. 31, 2013	58,536,972
Private Placement, Common Stock, Amount	158,129	9,221,751			9,379,880
Private Placement, Common Stock, Shares (in Shares)	15,812,808
Share-based compensation		880,765			880,765
Issuance of common stock in payment of accounts payable	1,898	260,170			262,068
Issuance of common stock in payment of accounts payable (in Shares)	189,752
Issuance of common stock in payment, amount	1,403	147,988			149,391
Issuance of common stock in payment, shares (in Shares)	140,396
Warrants issued in connection with March 2014 Debt Private Placement		443,267			443,267
Option exercises	1,625	141,375			143,000
Option exercises (in Shares)	162,500				162,500
Net loss for the year				(4,524,732)	(4,524,732)us-gaap_NetIncomeLoss
Balances, Convertible Preferred Stock Series A, Amount at Dec. 31, 2014	$ 748,424	$ 76,428,580		$ (77,277,334)	$ (100,330)us-gaap_StockholdersEquity
Balances, Convertible Preferred Stock Series A, Shares (in Shares) at Dec. 31, 2014	74,842,428